Drap Launches App to Combat Counterfeit Medicines in Pakistan

ISLAMABAD: The Drug Regulatory Authority of Pakistan (Drap) has launched the ‘Mehfooz Dawa’ application, urging consumers to verify the authenticity and prices of medicines to combat the growing issue of counterfeit drugs. This initiative comes as part of Drap’s ongoing efforts to ensure public safety and enhance the quality of healthcare in the country.

According to Sajid Shah, a spokesperson for the Ministry of National Health Services, approximately 800 pharmaceutical companies and over 90,000 medicines are registered with Drap. The newly introduced 2D barcode system allows consumers to scan medicine packs, ensuring they receive safe and effective products. The centralised track-and-trace system for pharmaceutical products, which became operational on October 9, aims to streamline the monitoring of medicine supply chains.

This development is significant for citizens, as it not only empowers them to make informed choices about their medications but also aids authorities in tracking supply chains and recalling products in response to complaints or quality concerns. With the ability to scan barcodes, smartphone users can access detailed product information and pricing, enhancing transparency in the pharmaceutical market.

Looking ahead, Drap plans to promote the app further and encourage widespread adoption among consumers. This initiative is expected to play a crucial role in safeguarding public health and restoring trust in the pharmaceutical sector.